1-6 of 6
Ann M. Bode
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo

Mengqiu Song, Xuejiao Liu, Kangdong Liu, Ran Zhao, Hai Huang, Yuanyuan Shi, Man Zhang, Silei Zhou, Hua Xie, Hanyong Chen, Yin Li, Yan Zheng, Qiong Wu, Fangfang Liu, Enmin Li, Ann M. Bode, Zigang Dong, Mee-Hyun Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1540–1553.
https://doi.org/10.1158/1535-7163.MCT-17-0823
Published: 01 July 2018
View article titled, Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <em>In Vitro</em> and Patient-Derived Xenografts <em>In Vivo</em>
Open the PDF for Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <em>In Vitro</em> and Patient-Derived Xenografts <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Targeting PRPK Function Blocks Colon Cancer Metastasis

Tatyana Zykova, Feng Zhu, Lei Wang, Haitao Li, Do Young Lim, Ke Yao, Eunmiri Roh, Sang-Pil Yoon, Hong-Gyum Kim, Ki Beom Bae, Weihong Wen, Seung Ho Shin, Janos Nadas, Yan Li, Weiya Ma, Ann M. Bode, Zigang Dong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (5): 1101–1113.
https://doi.org/10.1158/1535-7163.MCT-17-0628
Published: 30 April 2018
View article titled, Targeting PRPK Function Blocks Colon Cancer Metastasis
Open the PDF for Targeting PRPK Function Blocks Colon Cancer Metastasis in another window
Includes: Supplementary data
Journal Articles

ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Ge Gao, Tianshun Zhang, Qiushi Wang, Kanamata Reddy, Hanyong Chen, Ke Yao, Keke Wang, Eunmiri Roh, Tatyana Zykova, Weiya Ma, Joohyun Ryu, Clara Curiel-Lewandrowski, David Alberts, Sally E. Dickinson, Ann M. Bode, Ying Xing, Zigang Dong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (9): 1843–1854.
https://doi.org/10.1158/1535-7163.MCT-17-0212
Published: 04 September 2017
View article titled, ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK
Open the PDF for ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK in another window
Includes: Supplementary data
Journal Articles

The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications

Zheqiong Tan, Xiangjian Luo, Lanbo Xiao, Min Tang, Ann M. Bode, Zigang Dong, Ya Cao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (5): 774–782.
https://doi.org/10.1158/1535-7163.MCT-15-0621
Published: 05 May 2016
View article titled, The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
Open the PDF for The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications in another window
Journal Articles

Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo

Hua Xie, Mee-Hyun Lee, Feng Zhu, Kanamata Reddy, Zunnan Huang, Dong Joon Kim, Yan Li, Cong Peng, Do Young Lim, Soouk Kang, Sung Keun Jung, Xiang Li, Haitao Li, Weiya Ma, Ronald A. Lubet, Jian Ding, Ann M. Bode, Zigang Dong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 950–958.
https://doi.org/10.1158/1535-7163.MCT-12-1241
Published: 09 June 2013
View article titled, Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities <em>In Vitro</em> and <em>In Vivo</em> in another window
Journal Articles

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 972–979.
https://doi.org/10.1158/1535-7163.MCT-07-2141
Published: 15 April 2008
View article titled, Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Open the PDF for Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes in another window